Schedule of revenues disaggregated by category |
Revenues disaggregated by category were as follows (in thousands):
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
2025 |
|
2024 |
Product sales: |
|
|
|
|
|
|
Gross product sales |
|
$ |
60,192 |
|
$ |
38,426 |
Discounts and allowances |
|
|
(16,642) |
|
|
(12,423) |
Total product sales, net |
|
|
43,550 |
|
|
26,003 |
Revenues from collaborations: |
|
|
|
|
|
|
Milestone revenue |
|
|
3,000 |
|
|
— |
Delivery of drug supplies, royalty and others |
|
|
6,783 |
|
|
3,531 |
Total revenues from collaborations |
|
|
9,783 |
|
|
3,531 |
Total revenues |
|
$ |
53,333 |
|
$ |
29,534 |
|
Schedule of product revenue allowance and reserve categories |
The following tables summarize the activities in chargebacks, discounts and fees, government and other rebates and returns that were accounted for within revenue reserves and refund liability, for each of the periods presented (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chargebacks, |
|
Government |
|
|
|
|
|
|
Discounts and |
|
and Other |
|
|
|
|
|
|
Fees |
|
Rebates |
|
Returns |
|
Total |
Balance as of January 1, 2025 |
|
$ |
13,374 |
|
$ |
8,343 |
|
$ |
4,723 |
|
$ |
26,440 |
Provision related to current period sales |
|
|
12,811 |
|
|
3,654 |
|
|
398 |
|
|
16,863 |
Adjustment related to prior period sales |
|
|
— |
|
|
(148) |
|
|
(560) |
|
|
(708) |
Credit or payments made during the period |
|
|
(12,928) |
|
|
(1,669) |
|
|
(63) |
|
|
(14,660) |
Balance as of March 31, 2025 |
|
$ |
13,257 |
|
$ |
10,180 |
|
$ |
4,498 |
|
$ |
27,935 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chargebacks, |
|
Government |
|
|
|
|
|
|
|
|
Discounts and |
|
and Other |
|
|
|
|
|
|
|
|
Fees |
|
Rebates |
|
Returns |
|
Total |
Balance as of January 1, 2024 |
|
$ |
8,236 |
|
$ |
3,517 |
|
$ |
3,931 |
|
$ |
15,684 |
Provision related to current period sales |
|
|
9,763 |
|
|
2,280 |
|
|
224 |
|
|
12,267 |
Credit or payments made during the period |
|
|
(10,255) |
|
|
(1,609) |
|
|
(42) |
|
|
(11,906) |
Balance as of March 31, 2024 |
|
$ |
7,744 |
|
$ |
4,188 |
|
$ |
4,113 |
|
$ |
16,045 |
|